SLC22A6
solute carrier family 22 member 6
Pathway candidate — not linked to PFS or PSSD by any record here
Gene summary
A protein-coding gene on chromosome 11 (drug and xenobiotic transporters). The protein encoded by this gene is involved in the sodium-dependent transport and excretion of organic anions, some of which are potentially toxic. The protein is an integral membrane protein and may be localized to the basolateral membrane.
Source: NCBI Gene, accessed 2026-10-07.
Protein reference (UniProt)
- Protein
Solute carrier family 22 member 6
- Function (excerpt)
Secondary active transporter that functions as a Na(+)-independent organic anion (OA)/dicarboxylate antiporter where the uptake of one molecule of OA into the cell is coupled with an efflux of one molecule of intracellular dicarboxylate such as 2-oxoglutarate or glutarate. Mediates the uptake of OA across the basolateral side of proximal tubule epithelial cells, thereby contributing to the renal elimination of endogenous OA from the systemic circulation into the urine. Functions as a biopterin transporters involved in the uptake and the secretion of coenzymes tetrahydrobiopterin (BH4), dihydrobiopterin (BH2) and sepiapterin to urine, thereby determining baseline levels of blood biopterins. Transports prostaglandin E2 (PGE2) and prostaglandin F2-alpha (PGF2-alpha) and may contribute to their renal excretion. Also mediates the uptake of cyclic nucleotides such as cAMP and cGMP.
- Subcellular location
Basolateral cell membrane; Basal cell membrane.
- Tissue specificity
Strongly expressed in kidney. Expressed at lower level in liver, skeletal muscle, brain and placenta. In kidney, found at the basolateral membrane of the proximal tubule. In testis, primarily localized to the basal membrane of Sertoli cells and weakly expressed in Leydig cells and vascular endothelial cells.
Source: UniProtKB/Swiss-Prot Q4U2R8, release 2026_03, licensed CC BY 4.0. This is the protein’s normal biology, not evidence about post-drug syndromes; associated conditions are inherited disorders of the gene, not PFS, PSSD or PRSD.
Why its pathway is in the library
Transporters set systemic exposure to finasteride/SSRIs and clear conjugated steroid metabolites — directly relevant to both drug pharmacokinetics and Powers' clearance-centered PFS mechanism.
Written for the whole drug transporters family, not for SLC22A6 specifically.
Mentioned in 0 corpus records
No corpus record names SLC22A6 directly yet. It is in the library because it sits in a pathway the corpus tracks (Drug transporters).
Also in drug and xenobiotic transporters
All 62 genes- SLC6A4
solute carrier family 6 member 4
chr 17· Drug transporters· 10 records - ABCC2Powers
ATP binding cassette subfamily C member 2
chr 10· Drug transporters· 6 records - ABCC3Powers
ATP binding cassette subfamily C member 3
chr 17· Drug transporters· 5 records - ABCB1
ATP binding cassette subfamily B member 1
chr 7· Drug transporters· 3 records - ABCC5Powers
ATP binding cassette subfamily C member 5
chr 3· Drug transporters· 3 records - SLCO1B1Powers
solute carrier organic anion transporter family member 1B1
chr 12· Drug transporters· 4 records - SLC18A2
solute carrier family 18 member A2
chr 10· Drug transporters· 1 record - SLCO1B3
solute carrier organic anion transporter family member 1B3
chr 12· Drug transporters· 1 record
Browse by family on the gene families page.
